Skip to main content

Fentanyl Citrate Injection

Last Updated: January 12, 2023
Status: Current

Products Affected - Description
    • Fentanyl citrate solution for injection, Fresenius Kabi, 50 mcg/mL, 1 mL vial, 25 count, NDC 63323-0806-01
    • Fentanyl citrate solution for injection, Fresenius Kabi, 50 mcg/mL, 2 mL vial, 25 count, NDC 63323-0806-02
    • Fentanyl citrate solution for injection, Fresenius Kabi, 50 mcg/mL, 20 mL vial, 25 count, NDC 63323-0806-20
    • Fentanyl citrate solution for injection, Fresenius Kabi, 50 mcg/mL, 50 mL vial, 1 count, NDC 63323-0806-50
    • Fentanyl citrate solution for injection, Hikma, 50 mcg/mL, 1 mL vial, 25 count, NDC 00641-6247-25
    • Fentanyl citrate solution for injection, Hikma, 50 mcg/mL, 2 mL vial, 25 count, NDC 00641-6027-25
    • Fentanyl citrate solution for injection, Hikma, 50 mcg/mL, 20 mL vial, 1 count, NDC 00641-6029-01
    • Fentanyl citrate solution for injection, Hikma, 50 mcg/mL, 5 mL vial, 25 count, NDC 00641-6028-25
    • Fentanyl citrate solution for injection, Hikma, 50 mcg/mL, 50 mL vial, 1 count, NDC 00641-6030-01
    • Fentanyl citrate solution for injection, Pfizer, 50 mcg/mL, 10 mL vial, 25 count, NDC 00409-9094-28
    • Fentanyl citrate solution for injection, Pfizer, 50 mcg/mL, 2 mL Carpuject syringe, 10 count, NDC 00409-1276-32
    • Fentanyl citrate solution for injection, Pfizer, 50 mcg/mL, 2 mL ampule, 10 count, NDC 00409-9093-32
    • Fentanyl citrate solution for injection, Pfizer, 50 mcg/mL, 2 mL vial, 25 count, NDC 00409-9094-22
    • Fentanyl citrate solution for injection, Pfizer, 50 mcg/mL, 20 mL vial, 25 count, NDC 00409-9094-31
    • Fentanyl citrate solution for injection, Pfizer, 50 mcg/mL, 5 mL ampule, 10 count, NDC 00409-9093-35
    • Fentanyl citrate solution for injection, Pfizer, 50 mcg/mL, 5 mL vial, 25 count, NDC 00409-9094-25
    • Fentanyl citrate solution for injection, Pfizer, 50 mcg/mL, 50 mL vial, 25 count, NDC 00409-9094-61
Reason for the Shortage
    • Akorn has fentanyl injection available.
    • Fresenius Kabi had fentanyl on shortage due to increased demand.
    • Hikma had fentanyl injection on shortage due to supply and demand issues. They are not currently marketing fentanyl ampules, just vials.
    • Pfizer has fentanyl injection on shortage due to increased demand. The 20 mL ampules were discontinued in September 2017.
Available Products
    • Fentanyl citrate solution for injection, Akorn, 50 mcg/mL, 2 mL ampule, 10 count, NDC 17478-0030-02
    • Fentanyl citrate solution for injection, Akorn, 50 mcg/mL, 5 mL ampule, 10 count, NDC 17478-0030-05
    • Fentanyl citrate solution for injection, Fresenius Kabi, 50 mcg/mL, 1 mL syringe, 10 count, NDC 63323-0808-11
    • Fentanyl citrate solution for injection, Fresenius Kabi, 50 mcg/mL, 5 mL vial, 25 count, NDC 63323-0806-05

Estimated Resupply Dates

    • Fresenius Kabi has fentanyl 50 mcg/mL 1 mL, 2 mL, 20 mL, and 50 mL vials on back order and the company estimates a release date of late-January to early-February 2023 for the 1 mL and 50 mL vials, mid-January 2023 for the 2 mL vials, and late-January 2023 for the 20 mL vials.
    • Hikma has fentanyl 50 mcg/mL 1 mL, 5 mL, 20 mL, and 50 mL vials on back order and the company estimates a release date of mid-January 2023 for the 1 mL, 5 mL, and 50 mL vials and late-January 2023 for the 20 mL vials. The 2 mL vials are on allocation.
    • Pfizer has fentanyl 50 mcg/mL 2 mL ampules and 5 mL ampules on back order and the company estimates a release date of July 2023. The 5 mL vials are on back order and the company estimates a release date of January 2023. The 2 mL vials, 10 mL vials, 20 mL vials, and 50 mL vials are available in limited supply. The 2 mL Carpuject syringes are on back order and the company estimates a release date of February 2025.

Implications for Patient Care

Updated

Updated January 12, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 8, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.